JNJ Stock Quote - Johnson & Johnson Stock News, ResearchWarren Buffett Guru Investors

88.01 (1y: +39%)

Market Cap	245.42 B	P/E(ttm)	23.90
Enterprise Value	239.86 B	P/B	3.80

JNJ- NYSE (USA)
Johnson & Johnson

Currently 2.5/5

Business Predictability Rank: 2.5-Star
Back Testing Results:
Average gain of all 2.5-Star stocks: 7.3% per year.
% of Stocks that are in still loss if held for 10yrs: 18%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$88.01

6 Medium Warning Signs 2 Good Signs

Bookmark

Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score

Market Cap $M	245,416	Revenue $M	68,590	Net Margin (%)	16.1	Z-Score	4.9
Enterprise Value $M	239,861	EPS $	3.8	Operating Margin %	23.6	F-Score	5
P/E(ttm))	23.9	Cash Flow Per Share $	6.2	Pre-tax Margin (%)	20.5	Higher ROA y-y	Y
Price/Book	3.8	10-y EBITDA Growth Rate %	6.2	Quick Ratio	2.1	Cash flow > Earnings	Y
Price/Sales	3.6	5-y EBITDA Growth Rate %	1.5	Current Ratio	1.9	Lower Leverage y-y	Y
Price/Cash Flow	11.3	y-y EBITDA Growth Rate %	2.3	ROA % (ttm)	8.9	Higher Current Ratio y-y	N
Dividend Yield %	2.8	Insider Buy (3m)	0	ROE % (ttm)	16.7	Less Shares Outstanding y-y	N
Payout Ratio %	66.2	Shares Outstanding M	2,795	ROI % (ttm)	19.3	Gross Margin Increase y-y	N

Gurus Latest Trades with JNJ

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus

Number of guru portfolios checked: 51.

Total Records: 156 Page: FIRST

1 2 3 4 5 6 7 8

Ticker	Guru	Date	Action	Impact	Price Range (Average)*	Current Price	Change from Average	Comment	Current Shares
JNJ	Ruane Cunniff	2009-06-30	Add	0.01%	$50.65 - $56.96 ($54.11)	$ 88.01	63%	Add 22.8%	82,411
JNJ	Warren Buffett	2009-03-31	Add	0.5%	$47.97 - $58.56 ($54.2)	$ 88.01	62%	Add 13.62%	32,508,891
JNJ	Tweedy Browne	2009-03-31	Add	0.38%	$47.97 - $58.56 ($54.2)	$ 88.01	62%	Add 25.74%	510,461
JNJ	Jean-Marie Eveillard	2009-03-31	Add	0.21%	$47.97 - $58.56 ($54.2)	$ 88.01	62%	Add 27.41%	1,365,462
JNJ	John Hussman	2009-03-31	Add	0.84%	$47.97 - $58.56 ($54.2)	$ 88.01	62%	Add 32.5%	2,650,000
JNJ	Warren Buffett	2008-12-31	Reduce	-1.77%	$55.39 - $62.13 ($59)	$ 88.01	49%	Reduce -53.67%	28,611,591
JNJ	PRIMECAP Management	2008-12-31	Buy	0.35%	$55.39 - $62.13 ($59)	$ 88.01	49%	New holding, 2557900 sh.	2,557,900
JNJ	John Hussman	2008-12-31	Add	0.44%	$55.39 - $62.13 ($59)	$ 88.01	49%	Add 14.29%	2,000,000
JNJ	Meridian Funds	2008-12-31	Reduce	-0.01%	$55.39 - $62.13 ($59)	$ 88.01	49%	Reduce -37.26%	6,735
JNJ	Prem Watsa	2008-12-31	Add	2.04%	$55.39 - $62.13 ($59)	$ 88.01	49%	Add 29.59%	7,691,800
JNJ	Jean-Marie Eveillard	2008-09-30	Reduce	-0.38%	$64.7 - $71.42 ($69.1)	$ 88.01	27%	Reduce -51.68%	1,015,764
JNJ	George Soros	2008-09-30	Sold Out	-0.16%	$64.7 - $71.42 ($69.1)	$ 88.01	27%	Sold Out	0
JNJ	Vanguard Health Care Fund	2008-09-30	Reduce	-0.06%	$64.7 - $71.42 ($69.1)	$ 88.01	27%	Reduce -22.22%	700,000
JNJ	Richard Perry	2008-06-30	Reduce	-0.55%	$63.16 - $67.34 ($65.4)	$ 88.01	35%	Reduce -58.99%	599,341
JNJ	Vanguard Health Care Fund	2008-06-30	Reduce	-0.18%	$63.57 - $67.78 ($65.8)	$ 88.01	34%	Reduce -64%	900,000
JNJ	Jean-Marie Eveillard	2008-06-30	Reduce	-0.48%	$63.57 - $67.78 ($65.8)	$ 88.01	34%	Reduce -39.45%	2,102,174
JNJ	George Soros	2008-06-30	Add	0.09%	$63.57 - $67.78 ($65.8)	$ 88.01	34%	Add 142.31%	63,000
JNJ	Charles Brandes	2008-06-30	Sold Out	-0.01%	$63.57 - $67.78 ($65.8)	$ 88.01	34%	Sold Out	0
JNJ	Vanguard Health Care Fund	2008-03-31	Reduce	-0.61%	$61.51 - $67.43 ($63.6)	$ 88.01	38%	Reduce -24.24%	2,500,000
JNJ	Tweedy Browne	2008-03-31	Add	0.2%	$61.51 - $67.43 ($63.6)	$ 88.01	38%	Add 22.33%	418,053
Real Time Picks are included for Premium Members only!!

*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

Total Records: 156 Page: FIRST

1 2 3 4 5 6 7 8

JNJ is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus

Ticker	Guru Name	Portfolio Date*	Current Shares	% of Shares Outstanding	% of Total Assets Managed	Change from Last Holdings
JNJ	Yacktman Focused Fund	2013-03-31	3,800,000	0.14	4.24	+22.58%
JNJ	Donald Yacktman	2013-03-31	9,740,875	0.35	4.1	+16.02%
JNJ	Yacktman Fund	2013-03-31	4,050,000	0.14	3.88	+15.71%
JNJ	Mario Gabelli	2013-03-31	463,668	0.02	0.24	+4.95%
JNJ	James Barrow	2013-03-31	16,479,099	0.59	2.4	+1.32%
JNJ	Jean-Marie Eveillard	2013-03-31	1,541,960	0.06	0.42	+0.08%
JNJ	Tom Gayner	2013-03-31	592,850	0.02	1.8	+0.06%
JNJ	Michael Price	2013-03-31	45,000	0	0.48
JNJ	Meridian Funds	2013-03-31	7,885	0	0.02
JNJ	Prem Watsa	2013-03-31	5,941,600	0.21	18.1
JNJ	Richard Perry	2013-03-31	388,897	0.01	1
JNJ	Warren Buffett	2013-03-31	327,100	0.01	0.03
JNJ	Tweedy Browne	2013-03-31	4,355,404	0.16	9.2	-0.27%
JNJ	Dodge & Cox	2013-03-31	39,125	0	0	-0.51%
JNJ	George Soros	2013-03-31	2,534,022	0.09	2.4	-2.12%
JNJ	PRIMECAP Management	2013-03-31	13,647,387	0.49	1.6	-4.05%
JNJ	Vanguard Health Care Fund	2013-03-31	4,268,100	0.15	1.4	-5.15%
JNJ	Ruane Cunniff	2013-03-31	14,765	0	0.01	-8.86%
JNJ	Ray Dalio	2013-03-31	76,293	0	0.06	-55.3%
JNJ	Joel Greenblatt	2013-03-31	8,669	0	0.04	-58.46%
JNJ	John Hussman	2013-03-31	2,650	0	0.01	-99.47%

Most recent portfolio changes are included for Premium Members only!

JNJ: Insider Buys/Sells

Click Here for All Insider Trades.

Insider	Position	Date	Trades	Shares	Trade Price ($)	Change (%)	Details
CULLEN JAMES	Director	2013-05-07	Sell	4,929	$85.4	3.06	view
LINDQUIST SUSAN L	Director	2012-12-07	Sell	7,600	$70.02	25.69	view
CULLEN JAMES	Director	2012-11-12	Sell	13,900	$69.7	26.27	view
Caruso Dominic J	CFO	2012-10-19	Sell	20,400	$71.95	22.32	view
WELDON WILLIAM C	Chairman/CEO	2012-09-07	Sell	323,150	$67.66	30.08	view
COSGROVE STEPHEN J	Corporate Controller	2012-09-07	Sell	20,085	$67.78	29.85	view
COLEMAN MARY SUE	Director	2012-07-19	Sell	7,600	$69.26	27.07	view
DEYO RUSSELL C	VP, General Counsel	2012-02-22	Sell	156	$65	35.4	view
DEYO RUSSELL C	VP, General Counsel	2012-02-01	Sell	15,000	$65.79	33.77	view
WELDON WILLIAM C	Chairman/CEO	2012-02-01	Sell	448,085	$65.99	33.37	view

Press Releases about JNJ:

Johnson & Johnson to Host Analyst Conference Call on... 19 Mar 2013
Johnson & Johnson Comments on Venezuelan Currency... 25 Feb 2013
Johnson & Johnson to Participate in 2013 Citi Global Health... 20 Feb 2013
Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year... 22 Jan 2013
Johnson & Johnson Reports 2012 Third-Quarter Results: 16 Oct 2012

Quarterly/Annual Reports about JNJ:

10-Q - JOHNSON & JOHNSON (0000200406) (Filer): (10-Q) 08 Nov 2012
10-Q - JOHNSON & JOHNSON (0000200406) (Filer): (10-Q) 07 May 2012
10-K - JOHNSON & JOHNSON (0000200406) (Filer): (10-K) 23 Feb 2012
10-Q - JOHNSON & JOHNSON (0000200406) (Filer): (10-Q) 09 Aug 2011
10-Q - JOHNSON & JOHNSON (0000200406) (Filer): (10-Q) 10 May 2011

News about JNJ:

Articles On GuruFocus.com

20 Mega Caps and Their Dividend Payments and Which to Consider May 17 2013

Why would I not sell dividend stocks even after a 1000% gain? May 15 2013

Richard Pzena Buys 5 New Stocks May 14 2013

6 Dividend Stocks to Beat the Wall Street Giants May 14 2013

First Quarter 2013: Top and Bottom Performing Dividend Stocks May 07 2013

Donald Yacktman Buys Microsoft, Coca-Cola Co, CH Robinson, Sells H&R Block, Research in Motion May 02 2013

A Disciplined Approach to Dividend Stocks May 01 2013

Four Attractively Priced Dividend Stocks Boosting Distributions Apr 29 2013

Where is the Larger Bubble: the S&P 500 Index or U.S. Treasuries? Apr 26 2013

Many of My Dividend Growth Stocks Have Become Overvalued, What Do I Do Now? Apr 25 2013

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles